How would you treat cold agglutinin disease secondary to underlying marginal zone lymphoma with only bone marrow involvement and no disease elsewhere?

Would you consider a BTK inhibitor over rituximab? In the event of positive hepatitis B core antibody, would you add entecavir prophylaxis?